X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (21) 21
human necessities (21) 21
hygiene (21) 21
investigating or analysing materials by determining theirchemical or physical properties (21) 21
measuring (21) 21
medical or veterinary science (21) 21
metallurgy (21) 21
organic chemistry (21) 21
peptides (21) 21
physics (21) 21
preparations for medical, dental, or toilet purposes (21) 21
testing (21) 21
animals (10) 10
humans (9) 9
mice (8) 8
oncology (8) 8
cancer (7) 7
index medicus (7) 7
female (6) 6
life sciences (6) 6
xenograft model antitumor assays (5) 5
[ sdv.can ] life sciences [q-bio]/cancer (4) 4
[sdv.can]life sciences [q-bio]/cancer (4) 4
body regions (4) 4
skin and connective tissue diseases (4) 4
antineoplastic agents - pharmacology (3) 3
cell line, tumor (3) 3
cell proliferation - drug effects (3) 3
drug resistance, neoplasm (3) 3
expression (3) 3
gene expression regulation, neoplastic (3) 3
monoclonal antibodies (3) 3
pancreatic cancer (3) 3
proto-oncogene proteins - genetics (3) 3
activation (2) 2
antibodies, monoclonal - pharmacology (2) 2
antibodies, monoclonal, humanized - pharmacology (2) 2
antigens, surface - immunology (2) 2
beer (2) 2
biochemistry (2) 2
biochemistry, molecular biology (2) 2
cd3 complex - immunology (2) 2
cell biology (2) 2
compositions thereof (2) 2
culture media (2) 2
drug synergism (2) 2
enzymology (2) 2
epitopes - immunology (2) 2
genetics & heredity (2) 2
glutamate carboxypeptidase ii - immunology (2) 2
hct116 cells (2) 2
her3 (2) 2
inhibition (2) 2
intercellular signaling peptides and proteins - metabolism (2) 2
male (2) 2
membrane antigen (2) 2
mice, inbred nod (2) 2
mice, nude (2) 2
microbiology (2) 2
microorganisms or enzymes (2) 2
monoclonal-antibodies (2) 2
monoclonal-antibody (2) 2
mutation or genetic engineering (2) 2
overexpression (2) 2
phosphorylation - drug effects (2) 2
propagating, preserving or maintaining microorganisms (2) 2
proto-oncogene proteins - immunology (2) 2
proto-oncogene proteins - metabolism (2) 2
proto-oncogene proteins c-akt - metabolism (2) 2
proto-oncogene proteins p21 (2) 2
ras proteins - genetics (2) 2
receptor protein-tyrosine kinases - genetics (2) 2
receptor protein-tyrosine kinases - immunology (2) 2
receptor protein-tyrosine kinases - metabolism (2) 2
receptor, epidermal growth factor (2) 2
receptor, erbb-3 - metabolism (2) 2
regulatory t-cells (2) 2
signal transduction - drug effects (2) 2
specific therapeutic activity of chemical compounds ormedicinal preparations (2) 2
spirits (2) 2
targeted therapy (2) 2
tumor burden - drug effects (2) 2
tyrosine (2) 2
vinegar (2) 2
wine (2) 2
[ info.info-bt ] computer science [cs]/biotechnology (1) 1
[ sdv.bbm ] life sciences [q-bio]/biochemistry, molecular biology (1) 1
[ sdv.bio ] life sciences [q-bio]/biotechnology (1) 1
[ sdv.imm ] life sciences [q-bio]/immunology (1) 1
[ sdv.sp ] life sciences [q-bio]/pharmaceutical sciences (1) 1
[info.info-bt]computer science [cs]/biotechnology (1) 1
[sdv.bbm.bp]life sciences [q-bio]/biochemistry, molecular biology/biophysics (1) 1
[sdv.bc]life sciences [q-bio]/cellular biology (1) 1
[sdv.bio]life sciences [q-bio]/biotechnology (1) 1
[sdv.imm]life sciences [q-bio]/immunology (1) 1
abridged index medicus (1) 1
acquired-resistance (1) 1
amino acid sequence (1) 1
antibodies - metabolism (1) 1
antibodies, anti-idiotypic - administration & dosage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (36) 36
French (8) 8
German (4) 4
Korean (2) 2
Spanish (2) 2
Chinese (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 06/2017, Volume 23, Issue 11, pp. 2806 - 2816
Purpose: AXL receptor tyrosine kinase has been described as a relevant molecular marker and a key player in invasiveness, especially in triple-negative breast... 
EPITHELIAL-MESENCHYMAL TRANSITION | TARGET | SURVIVAL | STEM-CELLS | ONCOLOGY | DISEASE | GROWTH | FRA-1 | EXPRESSION | RECEPTOR TYROSINE KINASE | PROGRESSION | Proto-Oncogene Proteins - antagonists & inhibitors | Humans | Receptor Protein-Tyrosine Kinases - immunology | Antibodies, Anti-Idiotypic - immunology | Epithelial-Mesenchymal Transition - drug effects | Triple Negative Breast Neoplasms - therapy | Triple Negative Breast Neoplasms - immunology | Cell Movement - immunology | Xenograft Model Antitumor Assays | Cell Movement - drug effects | Antibodies, Anti-Idiotypic - administration & dosage | Neoplasm Metastasis | Animals | Heterografts | Triple Negative Breast Neoplasms - genetics | Signal Transduction - drug effects | Epithelial-Mesenchymal Transition - immunology | Proto-Oncogene Proteins - immunology | Triple Negative Breast Neoplasms - pathology | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Female | Cell Proliferation - drug effects | Mice | Gene Expression Regulation, Neoplastic - drug effects | Tyrosine | Mesenchyme | Invasiveness | Genes | Intracellular signalling | Breast cancer | Metastasis | Gene expression | Fra1 protein | Metastases | Axl protein | Cell adhesion & migration | Anticancer properties | Bone growth | Experimental design | Xenografts | Monoclonal antibodies | Breast | Antitumor activity | Protein-tyrosine kinase receptors | Inhibition | Protein-tyrosine kinase | Cell migration | Cancer | Life Sciences
Journal Article
Journal Article
The Journal of Pathology, ISSN 0022-3417, 09/2015, Volume 237, Issue 1, pp. 14 - 24
A tyrosine kinase network composed of the TAM receptor AXL and the cytoplasmic kinases LYN and SYK is involved in nilotinib‐resistance of chronic myeloid... 
inhibitors | tyrosine kinase | drug resistance | CHRONIC MYELOGENOUS LEUKEMIA | CELLS | ACTIVATION | PHOSPHORYLATION | BCR-ABL | PATHOLOGY | CANCER | UBIQUITINATION | OVEREXPRESSION | GENE | ONCOLOGY | HYDROGEN-PEROXIDE | Proto-Oncogene Proteins c-cbl - metabolism | Protein-Tyrosine Kinases - metabolism | Humans | Gene Expression Regulation, Neoplastic | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Drug Resistance, Neoplasm | Intracellular Signaling Peptides and Proteins - metabolism | Intercellular Signaling Peptides and Proteins - metabolism | Protein-Tyrosine Kinases - genetics | Transfection | RNA Interference | Time Factors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | src-Family Kinases - metabolism | Antineoplastic Agents - pharmacology | Intracellular Signaling Peptides and Proteins - genetics | Syk Kinase | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins c-cbl - genetics | Enzyme Stability | Proto-Oncogene Proteins - genetics | Pyrimidines - pharmacology | Receptor Protein-Tyrosine Kinases - metabolism | Gene Expression Regulation, Enzymologic | Receptor Protein-Tyrosine Kinases - genetics | Signal Transduction - drug effects | K562 Cells | Ligands | Protein Kinase Inhibitors - pharmacology | src-Family Kinases - genetics | Ubiquitin | Antimitotic agents | Tyrosine | Ligases | Phenols | Heat shock proteins | Drug resistance | Antineoplastic agents
Journal Article
Oncogene, ISSN 0950-9232, 11/2014, Volume 33, Issue 47, pp. 5405 - 5414
Journal Article
Journal Article
Journal Article
Neoplasia, ISSN 1476-5586, 2013, Volume 15, Issue 3, pp. 335 - IN40
Journal Article
Neoplasia (United States), ISSN 1522-8002, 2013, Volume 15, Issue 3, pp. 335 - 347
Blockade of the human epidermal growth factor receptor 3 (HER3) and of the downstream phosphatidylinositide 3-kinase (PI3K)/AKT pathway is a prerequisite for... 
INHIBITION | ERBB3 | ONCOLOGY | ACQUIRED-RESISTANCE | DOWN-REGULATION | MONOCLONAL-ANTIBODIES | FACTOR RECEPTOR | DECREASED SURVIVAL | CANCER | EXPRESSION | HER3
Journal Article
Cancer Research, ISSN 0008-5472, 04/2012, Volume 72, Issue 8 Supplement, pp. 1902 - 1902
Journal Article
Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. 975 - 975
Journal Article
Oncogene, ISSN 0950-9232, 11/2014, Volume 33, Issue 47, pp. 5405 - 14
AXL receptor tyrosine kinase (RTK) is implicated in proliferation and invasion of many cancers, particularly in pancreatic ductal adenocarcinoma (PDAC), for... 
Life Sciences | Cancer
Journal Article
Neoplasia (New York, N.Y.), ISSN 1522-8002, 3/2013, Volume 15, Issue 3, pp. 335 - 347
Blockade of the human epidermal growth factor receptor 3 (HER3) and of the downstream phosphatidylinositide 3-kinase (PI3K)/AKT pathway is a prerequisite for... 
Journal Article
Neoplasia : An International Journal for Oncology Research, ISSN 1522-8002, 03/2013, Volume 15, Issue 3, pp. 335 - 47
Blockade of the human epidermal growth factor receptor 3 (HER3) and of the downstream phosphatidylinositide 3-kinase (PI3K)/AKT pathway is a prerequisite for... 
Life Sciences | Biotechnology | Immunology | Computer Science | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.